Cyber Resilience

CVE-2020-27262

Medium

Published: 08 January 2021

Published
08 January 2021
Modified
21 November 2024
KEV Added
Patch
CVSS Score v3.1 5.4 CVSS:3.1/AV:N/AC:L/PR:L/UI:R/S:C/C:L/I:L/A:N
EPSS Score 0.0016 36.5th percentile
Risk Priority 11 60% EPSS · 20% KEV · 20% CVSS

Summary

CVE-2020-27262 is a medium-severity Cross-site Scripting (CWE-79) vulnerability in Innokasmedical Vital Signs Monitor Vc150 Firmware. Its CVSS base score is 5.4 (Medium).

Operationally, ranked at the 36.5th percentile by exploit likelihood (below the median); it is not currently listed in the CISA KEV catalog.

EU & UK References

Vulnerability details

Innokas Yhtymä Oy Vital Signs Monitor VC150 prior to Version 1.7.15 A stored cross-site scripting (XSS) vulnerability exists in the affected products that allow an attacker to inject arbitrary web script or HTML via the filename parameter to multiple update…

more

endpoints of the administrative web interface.

CWE(s)

Related Threats

No named actor attribution yet. ATT&CK technique mapping in progress for this CVE.

Affected Assets

innokasmedical
vital signs monitor vc150 firmware
≤ 1.7.15

Mitigating Controls

Likely Mitigating Controls AI

Per-CVE control mapping for this CVE has not run yet; the list below is derived from the weakness types (CWEs) cited in the NVD entry.

addresses: CWE-79

Penetration testing submits XSS payloads to web applications, detecting cross-site scripting flaws for subsequent remediation.

addresses: CWE-79

Validates web inputs to reject script-related content that could produce XSS.

addresses: CWE-79

Output validation against expected content can reject or sanitize script content in generated web pages, reducing XSS exploitability.

References